This predictive regression model of death following LT for HCC, based on AFP levels and tumor features (size and number), outperformed the Milan, UCSF, Up-to-Seven, and AFP-French criteria and has now been endorsed by both the European Liver and Intestine Transplant Association and the International Liver Transplantation Society. The gene discussed is AFP; the disease is hepatocellular carcinoma.